5-149028145-AC-CT
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PS1_ModeratePM1PM2PM5PP3PP5_Very_Strong
The ENST00000515425.6(SH3TC2):c.1586_1587delinsAG(p.Arg529Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R529H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000515425.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3TC2 | NM_024577.4 | c.1586_1587delinsAG | p.Arg529Gln | missense_variant | 11/17 | ENST00000515425.6 | NP_078853.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3TC2 | ENST00000515425.6 | c.1586_1587delinsAG | p.Arg529Gln | missense_variant | 11/17 | 1 | NM_024577.4 | ENSP00000423660 | P2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4C Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Oct 05, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Jan 12, 2024 | PS3, PM2, PM3_Strong, PM5_Supporting, PP3 - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 21, 2021 | The c.1586_1587delGTinsAG variant (also known as p.R529Q), located in coding exon 11 of the SH3TC2 gene, results from an in-frame deletion of GT and insertion of AG at nucleotide positions 1586 to 1587. This results in the substitution of the arginine residue for a glutamine residue at codon 529, an amino acid with highly similar properties. This variant has been reported in the literature in the homozygous state as well as in trans with another likely pathogenic alteration in multiple unrelated patients affected with neuropathy (Senderek J et al. Am. J. Hum. Genet., 2003 Nov;73:1106-19; Lupo V et al. Hum Mol Genet, 2009 Dec;18:4603-14; Yger M et al. J Peripher Nerv Syst, 2012 Mar;17:112-22; Iguchi M et al. Muscle Nerve, 2013 Feb;47:283-6). Functional studies showed an abnormal effect on protein function in an in vitro cell based assay and abnormal localization with reduction or absence from the plasma membrane (Lupo V et al. Hum Mol Genet, 2009 Dec;18:4603-14; Gouttenoire EA et al. Glia, 2013 Jul;61:1041-51). This amino acid position is highly conserved in available vertebrate species. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Charcot-Marie-Tooth disease type 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 529 of the SH3TC2 protein (p.Arg529Gln). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individuals with Charcot-Marie-Tooth disease type 4C (PMID: 14574644, 19744956, 21840889, 23281072, 28555600). ClinVar contains an entry for this variant (Variation ID: 216005). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SH3TC2 function (PMID: 19744956, 23553667). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at